Gastro-retentive drug delivery systems sales will rise through 2036, driven by floating drug delivery systems at 24.5% of the system type segment in 2026. The market is projected to grow from USD 18.9 billion in 2026 to USD 51.3 billion by 2036, creating an incremental opportunity of USD 32.38 billion.